Abstract
Background
Acute
myeloid
leukemia
(AML)
is
characterized
by
cellular
and
genetic
heterogeneity,
which
correlates
with
clinical
course.
Although
single-cell
RNA
sequencing
(scRNA-seq)
reflect
this
diversity
to
some
extent,
the
low
sample
numbers
in
individual
studies
limit
analytic
potential
of
comparisons
specific
patient
groups.
Results
We
performed
large
scale
integration
published
scRNA-seq
datasets
create
a
unique
transcriptomic
atlas
for
AML
(AML
scAtlas),
totaling
748,679
cells,
from
159
patients
44
healthy
donors
20
different
studies.
This
largest
data
resource
our
knowledge,
publicly
available
at
https://cellxgene.bmh.manchester.ac.uk/AML/.
scAtlas,
allowed
exploration
importance
age
t(8;21)
an
unprecedented
level,
given
in-utero
origin
pediatric
disease.
uncovered
age-associated
gene
regulatory
network
(GRN)
signatures,
we
validated
using
bulk
delineate
distinct
groups
divergent
biological
characteristics.
Furthermore,
additional
multiomic
dataset
(scRNA-seq
scATAC-seq),
created
de-noised
GRN
reflecting
previously
defined
age-related
signatures.
Conclusions
Applying
integrated
analysis
reveal
age-dependent
regulation
t(8;21),
perhaps
immature/fetal
HSC
prenatal
disease
vs
postnatal
origin.
Our
revealed
that
BCLAF1,
particularly
enriched
inferred
origin,
promising
prognostic
indicator.
The
scAtlas
provides
powerful
investigate
molecular
mechanisms
underlying
subtypes.
Cell,
Journal Year:
2023,
Volume and Issue:
186(11), P. 2456 - 2474.e24
Published: May 1, 2023
Systematic
evaluation
of
the
impact
genetic
variants
is
critical
for
study
and
treatment
human
physiology
disease.
While
specific
mutations
can
be
introduced
by
genome
engineering,
we
still
lack
scalable
approaches
that
are
applicable
to
important
setting
primary
cells,
such
as
blood
immune
cells.
Here,
describe
development
massively
parallel
base-editing
screens
in
hematopoietic
stem
progenitor
Such
enable
functional
variant
effects
across
any
differentiation
state.
Moreover,
they
allow
rich
phenotyping
through
single-cell
RNA
sequencing
readouts
separately
characterization
editing
outcomes
pooled
genotyping.
We
efficiently
design
improved
leukemia
immunotherapy
approaches,
comprehensively
identify
non-coding
modulating
fetal
hemoglobin
expression,
define
mechanisms
regulating
differentiation,
probe
pathogenicity
uncharacterized
disease-associated
variants.
These
strategies
will
advance
effective
high-throughput
variant-to-function
mapping
hematopoiesis
causes
diverse
diseases.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Jan. 2, 2024
Abstract
Single-cell
transcriptomics
has
become
the
definitive
method
for
classifying
cell
types
and
states,
can
be
augmented
with
genotype
information
to
improve
lineage
identification.
Due
constraints
of
short-read
sequencing,
current
methods
detect
natural
genetic
barcodes
often
require
cumbersome
primer
panels
early
commitment
targets.
Here
we
devise
a
flexible
long-read
sequencing
workflow
analysis
pipeline,
termed
nanoranger
,
that
starts
from
intermediate
single-cell
cDNA
libraries
lineage-defining
features,
including
single-nucleotide
variants,
fusion
genes,
isoforms,
sequences
chimeric
antigen
TCRs.
Through
systematic
these
classes
‘barcodes’,
define
optimal
targets
nanoranger,
namely
those
loci
close
5’
end
highly
expressed
genes
transcript
lengths
shorter
than
4
kB.
As
proof-of-concept,
apply
longitudinal
tracking
subclones
acute
myeloid
leukemia
(AML)
describe
heterogeneous
isoform
landscape
thousands
marrow-infiltrating
immune
cells.
We
propose
enhanced
cellular
genotyping
using
tumor
co-evolution.
American Journal of Clinical Pathology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 3, 2025
Detection
of
minimal/measurable
disease
(MRD)
in
acute
myeloid
leukemia
(AML)
is
critical
for
both
clinical
decision-making
and
prognostication,
yet
remains
a
challenge.
Flow
cytometry
well-established
method
MRD
detection.
cytometric
(FC)
evaluation
must
consider
complex
maturational
pattern
normal
hematopoietic
development
to
separate
from
abnormal
progenitors.
Here,
we
offer
an
example
interpretive
approach
based
on
thorough
understanding
stage-
lineage-specific
maturation.
We
provide
comprehensive
overview
blast
maturation
early
precursors
(hematopoietic
stem
cells)
committed
late-stage
unilineage
progenitors
commonly
observed
stage-specific
abnormalities
cases
have
encountered
practice.
emphasize
the
importance
comparisons
accurate
detection
by
flow
cytometry.
The
AML
blasts
almost
invariably
show
phenotypes,
phenotypes
may
evolve
upon
therapy.
detected
are
necessarily
confined
target
antigens
included
panel.
It
therefore
evaluate
range
establish
specific
stage/state
lineage
commitment
detect
potential
common
abnormalities.
Moreover,
enough
cells
be
acquired
allow
at
desired
levels.
Significant
technical
analytical
validation
critical.
offers
powerful
single-cell-based
platform
AML,
results
been
proven
management.
Leukemia-associated
phenotype-informed
difference
presented
this
review
presents
framework
sensitive
Blood Cancer Discovery,
Journal Year:
2023,
Volume and Issue:
4(5), P. 394 - 417
Published: July 19, 2023
Abstract
Cancer
initiation
is
orchestrated
by
an
interplay
between
tumor-initiating
cells
and
their
stromal/immune
environment.
Here,
adapted
single-cell
RNA
sequencing,
we
decipher
the
predicted
signaling
tissue-resident
hematopoietic
stem/progenitor
(HSPC)
neoplastic
counterparts
with
native
niches
in
human
bone
marrow.
LEPR+
stromal
are
identified
as
central
regulators
of
hematopoiesis
through
interactions
all
Inflammatory
niche
remodeling
resulting
deprivation
critical
HSPC
regulatory
factors
to
repress
high-output
stem
cell
subsets
NPM1-mutated
acute
myeloid
leukemia
(AML),
relative
resistance
clonal
cells.
Stromal
gene
signatures
reflective
associated
reduced
relapse
rates
favorable
outcomes
after
chemotherapy
across
genetic
risk
categories.
Elucidation
intercellular
defining
AML,
thus,
predicts
that
inflammatory
drives
tissue
repression
selection
but
may
pose
a
vulnerability
for
relapse-initiating
context
chemotherapeutic
treatment.
Significance:
Tumor-promoting
inflammation
considered
enabling
characteristic
tumorigenesis,
mechanisms
remain
incompletely
understood.
By
deciphering
environment,
identify
determinant
normal
clinical
AML.
See
related
commentary
Lisi-Vega
Méndez-Ferrer,
p.
349.
This
article
featured
Selected
Articles
from
Issue,
337
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: Oct. 27, 2023
Single-cell
sequencing
is
a
technique
for
detecting
and
analyzing
genomes,
transcriptomes,
epigenomes
at
the
single-cell
level,
which
can
detect
cellular
heterogeneity
lost
in
conventional
hybrid
samples,
it
has
revolutionized
our
understanding
of
genetic
complexity
tumor
progression.
Moreover,
microenvironment
(TME)
plays
crucial
role
formation,
development
response
to
treatment
tumors.
The
application
ushered
new
age
TME
analysis,
revealing
not
only
blueprint
pan-cancer
immune
microenvironment,
but
also
differentiation
routes
cells,
as
well
predicting
prognosis.
Thus,
combination
analysis
provides
unique
opportunity
unravel
molecular
mechanisms
underlying
In
this
review,
we
summarize
recent
advances
highlighting
their
potential
applications
cancer
research
clinical
translation.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 1, 2024
Summary
Current
approaches
to
lineage
tracing
of
stem
cell
clones
require
genetic
engineering
or
rely
on
sparse
somatic
DNA
variants,
which
are
difficult
capture
at
single-cell
resolution.
Here,
we
show
that
targeted
measurements
methylation
single-CpG
resolution
deliver
joint
information
about
cellular
differentiation
state
and
clonal
identities.
We
develop
EPI-clone,
a
droplet-based
method
for
transgene-free
tracing,
apply
it
study
hematopoiesis,
capturing
hundreds
trajectories
across
almost
100,000
single-cells.
Using
ground-truth
barcodes,
demonstrate
EPI-clone
accurately
identifies
lineages
throughout
hematopoietic
differentiation.
Applied
unperturbed
describe
an
overall
decline
complexity
during
murine
ageing
the
expansion
rare
low-output
clones.
In
aged
human
donors,
identified
expanded
with
without
lesions,
various
degrees
complexity.
Taken
together,
enables
accurate
scale.